Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 205
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03479073 | Risk Factors of Stroke or Systemic Embolism After Atrial Fibrillation Ablation | ||
| NCT05481307 | A Study to Evaluate Pharmacokinetic/Pharmacodynamic Drug-drug Interaction and Safety/Tolerability Between RLD2202 and RLD2203 | ||
| NCT01638286 | Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects | ||
| NCT02545829 | Evaluating the Bioequivalence of HIP1302, HGP1406 | ||
| NCT04768686 | FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | ||
| NCT01806818 | Comparing Efficacy and Safety Between Eperisone a BID and a TID Regimen in Acute Low Back Pain Patients | ||
| NCT01509209 | Efficacy/Safety of Pseudoephedrine Plus Levocetirizine Versus Placebo in Patients With Vasomotor Rhinitis | ||
| NCT01442987 | Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia | ||
| NCT02940314 | Safety and Pharmacokinetic Characteristics After Administration of HIP1503 and HGP1103 in Healthy Male Volunteers | ||
| NCT02941848 | Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers | ||
| NCT05862090 | A Study to Evaluate the Drug-drug Interaction and Safety of RLD2301 and RLD2007 in Healthy Volunteers | ||
| NCT06234397 | Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects | ||
| NCT02418689 | Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens | ||
| NCT03212625 | The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | ||
| NCT01093729 | A Study of HM11260C in Healthy Male Subject | ||
| NCT04324918 | Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis | ||
| NCT02059564 | A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT02243319 | Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 | ||
| NCT04788290 | An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol | ||
| NCT02026817 | Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 10mg | ||
| NCT02239484 | Evaluating a Pharmacokinetic Drug Interaction Between Tadalafil and Tamsulosin | ||
| NCT04652349 | Efficacy and Safety of HGP1910 and HCP1903 in Patients With Primary Hypercholesterolemia | ||
| NCT04829149 | Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea | ||
| NCT04080726 | Efficacy and Safety of HIP1601 Capsule | ||
| NCT01746771 | A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer | ||
| NCT05656092 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | ||
| NCT02485652 | Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the Lung | ||
| NCT02057887 | Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) | ||
| NCT05711381 | Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function | ||
| NCT01509196 | A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet | ||
| NCT02081118 | Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes | ||
| NCT02302443 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12470 | ||
| NCT01452451 | Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT02916602 | A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605 | ||
| NCT05598151 | Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors | ||
| NCT07449754 | Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma | ||
| NCT02587988 | Trial to Evaluate the Efficacy and Safety of HCP1302 | ||
| NCT02941679 | Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients | ||
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT03332836 | Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus | ||
| NCT05199129 | Clinical Efficacy and Safety Evaluation of HCP1904-3 in Essential Hypertension Patients | ||
| NCT04324905 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers | ||
| NCT01013064 | A Study of HM10760A (Long-acting Erythropoietin (EPO)) in Healthy Korean Subjects | ||
| NCT04975711 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP2105 to RLD2104 in Healthy Volunteers | ||
| NCT04775706 | Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects | ||
| NCT04820907 | Clinical Efficacy and Safety Evaluation of HCP1904-1 in Essential Hypertension Patients | ||
| NCT06481098 | A Phase 1 Study to Assess HM15275 in Healthy and Obese Subjects. | ||
| NCT01555398 | Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule | ||
| NCT05450601 | A Study to Evaluate the Efficacy and Safety of HCP2102 in Essential Hypertension Patients |
